IE912025A1 - Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use - Google Patents

Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use

Info

Publication number
IE912025A1
IE912025A1 IE202591A IE202591A IE912025A1 IE 912025 A1 IE912025 A1 IE 912025A1 IE 202591 A IE202591 A IE 202591A IE 202591 A IE202591 A IE 202591A IE 912025 A1 IE912025 A1 IE 912025A1
Authority
IE
Ireland
Prior art keywords
methyl
compound according
compound
benzimidazole
carbon atoms
Prior art date
Application number
IE202591A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IE912025A1 publication Critical patent/IE912025A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IE202591A 1990-06-20 1991-06-14 Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use IE912025A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
IE912025A1 true IE912025A1 (en) 1992-01-01

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
IE202591A IE912025A1 (en) 1990-06-20 1991-06-14 Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use

Country Status (27)

Country Link
EP (1) EP0535081A1 (enrdf_load_stackoverflow)
JP (1) JPH05507713A (enrdf_load_stackoverflow)
CN (1) CN1058212A (enrdf_load_stackoverflow)
AP (1) AP215A (enrdf_load_stackoverflow)
AU (1) AU649453B2 (enrdf_load_stackoverflow)
BG (1) BG97200A (enrdf_load_stackoverflow)
CA (1) CA2083714A1 (enrdf_load_stackoverflow)
CZ (1) CZ279772B6 (enrdf_load_stackoverflow)
FI (1) FI925766A7 (enrdf_load_stackoverflow)
HU (1) HUT62881A (enrdf_load_stackoverflow)
IE (1) IE912025A1 (enrdf_load_stackoverflow)
IL (1) IL98470A0 (enrdf_load_stackoverflow)
IS (1) IS3721A7 (enrdf_load_stackoverflow)
LT (2) LT3952B (enrdf_load_stackoverflow)
LV (1) LV10953A (enrdf_load_stackoverflow)
MA (1) MA22199A1 (enrdf_load_stackoverflow)
NO (1) NO924775L (enrdf_load_stackoverflow)
NZ (1) NZ238546A (enrdf_load_stackoverflow)
OA (1) OA09682A (enrdf_load_stackoverflow)
PT (1) PT98035A (enrdf_load_stackoverflow)
RO (1) RO110493B1 (enrdf_load_stackoverflow)
SE (1) SE9002206D0 (enrdf_load_stackoverflow)
TN (1) TNSN91049A1 (enrdf_load_stackoverflow)
TW (1) TW216418B (enrdf_load_stackoverflow)
WO (1) WO1991019711A1 (enrdf_load_stackoverflow)
YU (1) YU104191A (enrdf_load_stackoverflow)
ZA (2) ZA914297B (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
ATE281164T1 (de) 2000-02-24 2004-11-15 Kopran Res Lab Ltd Oral verabreichbare säurebeständige geschwürbehandelnde benzimidazolderivate
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
AU2003246792B2 (en) 2002-04-09 2008-08-28 Flamel Ireland Limited Oral suspension of active principle microcapsules
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
EP2065379A4 (en) * 2006-10-13 2011-01-19 Eisai R&D Man Co Ltd BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION
EP2344139A1 (en) 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
JP2012531409A (ja) 2009-06-25 2012-12-10 アストラゼネカ・アクチエボラーグ Ｎｓａｉｄ関連潰瘍を発症するリスクがある患者の処置方法
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
CA3036250C (en) 2016-09-14 2023-09-26 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (enrdf_load_stackoverflow) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
KR890701580A (ko) * 1987-10-30 1989-12-21 앤더스 베딘 골(骨)손실에 관련된 질병 치료용 2-피리디닐메틸(술피닐 또는 티오) 벤즈이미다졸
WO1989005299A1 (en) * 1987-12-11 1989-06-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Also Published As

Publication number Publication date
PT98035A (pt) 1992-03-31
TNSN91049A1 (fr) 1992-10-25
EP0535081A1 (en) 1993-04-07
FI925766A0 (fi) 1992-12-18
SE9002206D0 (sv) 1990-06-20
AU8009791A (en) 1992-01-07
LT3952B (en) 1996-05-27
CZ279772B6 (cs) 1995-06-14
YU104191A (sh) 1994-01-20
MA22199A1 (fr) 1992-04-01
LV10953A (lv) 1995-12-20
IL98470A0 (en) 1992-07-15
LTIP1712A (en) 1995-08-25
AP215A (en) 1992-09-02
FI925766A7 (fi) 1992-12-18
BG97200A (bg) 1993-12-24
LTIP1713A (en) 1995-08-25
ZA914296B (en) 1992-03-25
AP9100285A0 (en) 1991-07-31
IS3721A7 (is) 1991-12-21
LT3977B (en) 1996-06-25
TW216418B (enrdf_load_stackoverflow) 1993-11-21
CA2083714A1 (en) 1991-12-21
JPH05507713A (ja) 1993-11-04
NO924775D0 (no) 1992-12-10
OA09682A (en) 1993-05-15
HUT62881A (en) 1993-06-28
ZA914297B (en) 1992-03-25
HU9204033D0 (en) 1993-03-29
CS189491A3 (en) 1992-04-15
AU649453B2 (en) 1994-05-26
RO110493B1 (ro) 1996-01-30
WO1991019711A1 (en) 1991-12-26
NO924775L (no) 1992-12-10
CN1058212A (zh) 1992-01-29
NZ238546A (en) 1994-03-25

Similar Documents

Publication Publication Date Title
AP215A (en) Substituted benzimidazoles, process for their preparation and their pharmaceutical use.
EP0593463B1 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0449940B1 (en) New therapeutically active compound and a process for its preparation
US4965269A (en) Therapeutically active chloro substituted benzimidazoles
EP0451188B1 (en) Therapeutically active substituted benzimidazole and process for its preparation
EP0449935B1 (en) Compound with gastric acid inhibitory effect and process for its preparation
WO1987005021A1 (en) Benzimidazoles and their pharmaceutical use
WO1995015962A1 (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
IE904248A1 (en) Therapeutically active fluoro substituted benzimidazoles,¹processes for their preparation as well as their use